This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Provectus Pharmatech, Inc, The University of Tennessee Research Foundation. Active years: 2026.
Company Filing History:
1 out of 26 
1 out of 785 
Years Active: 2026
Title: John Lacey, III: Innovator in Ophthalmic Treatments
Introduction
John Lacey, III is a notable inventor based in Knoxville, TN, recognized for his contributions to the field of ophthalmology. He holds a patent for a unique topical ophthalmic composition aimed at treating Gram-positive bacterial infections in the eye. His innovative approach combines scientific research with practical applications, showcasing his dedication to improving healthcare.
Latest Patents
Lacey's patent, titled "Halogenated xanthene-containing topical anti-gram-positive bacterial ophthalmic composition and method," presents a groundbreaking system for treating Gram-positive bacterial infections in mammalian eyes. The composition includes a halogenated fluorescein or a pharmaceutically acceptable salt or ester, dissolved in an aqueous carrier. It is designed to be effective at concentrations ranging from about 0.2 μg/mL to about 50 μg/mL. The formulation maintains a pH of approximately 6.5 to 7.6, a viscosity of about 10 to 300 cps, and an osmolality of around 270 mOsm/kg to 340 mOsm/kg. The composition is stored in a vessel that is opaque to actinic light, ensuring its efficacy. The method of treatment involves administering the composition to the infected eye while keeping it in the absence of actinic light for a duration of 3 to 12 hours.
Career Highlights
Throughout his career, John Lacey, III has worked with prominent organizations, including Provectus Pharmatech, Inc. and the University of Tennessee Research Foundation. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in ophthalmic treatments.
Collaborations
Lacey has collaborated with various professionals, including his coworker Dominic Rodrigues. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new treatments.
Conclusion
John Lacey, III is a distinguished inventor whose work in ophthalmic compositions has the potential to significantly impact the treatment of bacterial infections in the eye. His dedication to research and innovation continues to inspire advancements in healthcare.